Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)

NCT04314531 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

296

Enrollment

INDUSTRY

Sponsor class

Conditions

Active Psoriatic Arthritis

Interventions

DRUG: TILD
DRUG: matching placebo injections

Sponsor

Sun Pharmaceutical Industries Limited